e-learning
resources
Milan 2017
Wednesday, 13.09.2017
The acute patient: the clinical point-of-view
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The influence of trimetazidine (Tmz) on quality of life in patients with IPAH
T. Martynyuk (Moscow, Switzerland)
Source:
International Congress 2017 – The acute patient: the clinical point-of-view
Session:
The acute patient: the clinical point-of-view
Session type:
Poster Discussion
Number:
4739
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Martynyuk (Moscow, Switzerland). The influence of trimetazidine (Tmz) on quality of life in patients with IPAH. 4739
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The influence of fenspiride in complex therapy on quality of life in COPD patients
Source: Annual Congress 2010 - COPD: management
Year: 2010
NVA237 once daily improves dyspnea and health-related quality of life (HRQoL) in patients with COPD: The GLOW1 trial
Source: Annual Congress 2011 - Bronchodilators in asthma and COPD
Year: 2011
Indacaterol once-daily improves health-related quality of life (HRQOL) in COPD patients: a 52-week study
Source: Annual Congress 2009 - New bronchodilators
Year: 2009
Influence of tiotropium bromide (TB) on the severity of clinical, functional symptoms and health-related quality of life (HRQL) in COPD patients (pts)
Source: Annual Congress 2011 - COPD management
Year: 2011
Budesonide/formoterol adjustable maintenance dosing (AMD) improves health-related quality of life (HRQL) compared with high-dose budesonide (AMD)
Source: Eur Respir J 2004; 24: Suppl. 48, 311s
Year: 2004
Evaluation of quality of life (QOL) in asthma patients during 6 months formoterol therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 44s
Year: 2001
Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
Sildenafil improves health-related quality of life in pulmonary arterial hypertension (PAH) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 563s
Year: 2005
Health-related quality of life (HRQL) and use of formoterol in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 55s
Year: 2001
Indacaterol once-daily improves health-related quality of life in COPD patients: a 26-week comparison with placebo and tiotropium
Source: Annual Congress 2009 - New bronchodilators
Year: 2009
Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)
Source: Eur Respir J 2010; 35: 118-123
Year: 2010
Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
NIPPV‘s influence in severe COPD patients health-related quality of life
Source: Eur Respir J 2006; 28: Suppl. 50, 186s
Year: 2006
Effects of tadalafil on health-related quality of life in patients with pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009
Health-related quality of life (HRQL) and patient-reported outcomes (PRO) in COPD patients receiving add-on-therapy with EPs® 7630
Source: Annual Congress 2011 - COPD management
Year: 2011
Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Group therapy as a technique to improve quality of life in asthmatic patients
Source: Eur Respir J 2006; 28: Suppl. 50, 843s
Year: 2006
Patients with COPD using salmeterol/fluticasone propionate combination therapy experience improved quality of life
Source: Eur Respir J 2003; 22: Suppl. 45, 51s
Year: 2003
Does rehabilitation improve health-related quality of life (HRQL) in patients with advanced respiratory failure?
Source: Annual Congress 2007 - Health-related quality of life (HRQL) in patients with severe chronic respiratory failure
Year: 2007
Subtle assessment of quality of life in PH patients on inhaled iloprost treatment
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept